Delta-like ligand 4-Notch signaling regulates bone marrow-derived pericyte/vascular smooth muscle cell formation

Blood

Volumn 117, Issue 2, 2011, Pages 719-726

  Stewart, Keri Schadler ^a   Zhou, Zhichao ^a   Zweidler McKay, Patrick ^a   Kleinerman, Eugenie S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA LIKE LIGAND 4; MEMBRANE PROTEIN; NEUTRALIZING ANTIBODY; NOTCH RECEPTOR; UNCLASSIFIED DRUG; YW 152F;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BONE MARROW CELL; CANCER INHIBITION; CONTROLLED STUDY; EMBRYO; EWING SARCOMA; GENETIC TRANSFECTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 78751532798     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-05-284869     Document Type: Article

References (25)

1. Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neurooncology. 2005;7(4):452-464. (Pubitemid 41555617)
2. Chan-Ling T, Page MP, Gardiner T, Baxter L, Rosinova E, Hughes S. Desmin ensheathment ratio as an indicator of vessel stability: Evidence in normal development and in retinopathy of prematurity. Am J Pathol. 2004;165(4):1301- 1313. (Pubitemid 39297735)
3. Hirschi KK, Rohovsky SA, D'Amore PA. PDGF, TGF-β, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol. 1998;141(3):805-814.
4. Benjamin LE, Golijanin D, Itin A, Pode D, Keshet E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest. 1999;103(2):159-165. (Pubitemid 29053133)
5. Yu L, Su B, Hollomon M, Deng Y, Facchinetti V, Kleinerman ES. Vasculogenesis driven by bone marrow-derived cells is essential for growth of Ewing's sarcomas. Cancer Res. 2010;70(4):1334-1343.
6. Zhou Z, Reddy K, Guan H, Kleinerman ES. VEGF165, but not VEGF189, stimulates vasculogenesis and bone marrow cell migration into Ewing's sarcoma tumors In vivo. Mol Cancer Res. 2007;5(11):1125-1132. (Pubitemid 350137108)
7. Reddy K, Zhou Z, Schadler K, Jia SF, Kleinerman ES. Bone marrow subsets differentiate into endothelial cells and pericytes contributing to Ewing's tumor vessels. Mol Cancer Res. 2008;6(6):929-936.
8. Fortini ME. Notch signaling: the core pathway and its posttranslational modification. Dev Cell. 2009;16(5):633-647.
9. Zweidler-McKay PA. Notch signaling in pediatric malignancies. Curr Oncol Rep. 2008;10:459-468.
10. Shutter JR, Song S, Fan W, et al. Dll4, a novel Notch ligand expressed in arterial endothelium. Genes Dev. 2000;14(11):1313-1318. (Pubitemid 30397075)
11. Lobov IB, Renard RA, Papadopoulos N, et al. Delta-like ligand 4 (DLL4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci U S A. 2007;104(9):3219-3224. (Pubitemid 46364140)
12. Noguera-Troise I, Papadopoulos N, Coetzee S, et al. Blockade of DLL4 inhibits tumour growth by promoting non-productive angiogenesis. Nature. 2006;444:1032-1037.
13. Ridgway J, Zhang G, Wu Y, et al. Inhibition of DLL4 signalling inhibits tumor growth by deregulating angiogenesis. Nature. 2006;444:1083-1087.
14. Scehnet JS, Jiang W, Kumar SR, et al. Inhibition of DLL4 mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood. 2007;109(11):4753-4760.
15. Patel NS, Dobbie MS, Rochester M, et al. Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer. Clin Cancer Res. 2006;12(16):4836-4844.
16. Schadler KL, Zweidler-McKay PA, Guan H, Kleinerman ES. Delta-like ligand 4 plays a critical role in pericyte/vascular smooth muscle cell formation during vasculogenesis and tumor vessel expansion in Ewing's sarcoma. Clin Cancer Res. 2010;16(3):848-856.
17. + stem cells into the expanding tumor vasculature. Int J Cancer. 2006;119(4):839-846.
18. Hellström M, Phng LK, Hofmann JJ, et al. DLL4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature. 2007:1-5.
19. High FA, Lu MM, Pear WS, Loomes KM, Kaestner KH, Epstein JA. Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development. Proc Natl Acad Sci U S A. 2008;105(6):1955-1959.
20. Tang Y, Urs S, Boucher J, et al. Notch and transforming growth factor-beta (TGFbeta) signaling pathways cooperatively regulate vascular smooth muscle cell differentiation. J Biol Chem. 2010;285(23):17556-17563.
21. Lovschall H, Mitsiadis TA, Poulsen K, Jensen KH, Kjeldsen AL. Coexpression of Notch3 and Rgs5 in the pericyte-vascular smooth muscle cell axis in response to pulp injury. Int J Dev Biol. 2007;51:715-721. (Pubitemid 350205606)
22. Li Y, Takeshita K, Liu PY, et al. Smooth muscle notch1 mediates neointimal formation after vascular injury. Circulation. 2009;119(20):2686-2692.
23. Doi H, Iso T, Shiba Y, et al. Notch signaling regulates the differentiation of bone marrow-derived cells into smooth muscle-like cells during arterial lesion formation. Biochem Biophys Res Commun. 2009;381(4):654-659.
24. Reddy K, Zhou Z, Jia SF, et al. Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor. Int J Cancer. 2008;123(4):831-837. (Pubitemid 352032409)
25. Bolontrade MF, Zhou RR, Kleinerman ES. Vasculogenesis plays a role in the growth of Ewing's sarcoma in vivo. Clin Cancer Res. 2002;8(11):3622-3627.